is never the best treatment when we have a diagnosis of ectopic pregnancy.
If a pregnant woman with prolonged premature rupture of membranes (PPROM) reaches 34 weeks' gestation, it's probably in the mother's and the baby's best interests to deliver the baby rather than continue expectant management
, according to a single-institution observational study (Obstet.
Obstetricians should always provide expectant management
with well-defined indications for delivery in mind, as well as well-defined goals for gestational age at delivery that take into account their facility's practices and capabilities.
Previous studies have demonstrated a beneficial effect of corticosteroids during expectant management
in women with early-onset preeclampsia and HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome.
Considering the serious nature of this complication, however, it is reasonable to conclude that women with HELLP syndrome are not candidates for expectant management
and should be delivered regardless of their gestational age.
Because of strong preferences for expectant management
(EM), 59 women were randomized in the RCT (30 curettage, 29 EM) and 197 women were followed prospectively (65 curettage, 132 EM).
This practice is mainly accompanied with misdiagnosis and undiagnosis of eligible cases for expectant management
utilization for prostate cancer by hospital type and diagnosis year.
However, expectant management
could also be considered acceptable to deal with post-term pregnancies, using regular antenatal fetal surveillance to monitor fetal wellbeing.
With advances in technology and knowledge around infertility I think it's time to revisit the guidance on Expectant Management
So a team of researchers in Scotland compared rates of perinatal mortality and maternal complications after elective induction (induction of labour with no recognised medical indication) and expectant management
(continuation of pregnancy to either spontaneous labour or induction or caesarean section at a later date).
The aggregate primary end point of the Reduction With Dutasteride of Clinical Progression Events in Expectant Management
(REDEEM) study was time to either therapeutic or pathological progression.